Danaher Co. (NYSE:DHR) Shares Purchased by Legacy Private Trust Co.

Legacy Private Trust Co. boosted its position in shares of Danaher Co. (NYSE:DHR) by 5.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 25,937 shares of the conglomerate’s stock after buying an additional 1,324 shares during the period. Legacy Private Trust Co.’s holdings in Danaher were worth $5,954,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. First Hawaiian Bank raised its position in Danaher by 10.9% in the 4th quarter. First Hawaiian Bank now owns 5,220 shares of the conglomerate’s stock valued at $1,198,000 after purchasing an additional 512 shares during the last quarter. Douglas Lane & Associates LLC increased its stake in Danaher by 3.8% in the fourth quarter. Douglas Lane & Associates LLC now owns 330,715 shares of the conglomerate’s stock valued at $75,916,000 after purchasing an additional 11,989 shares during the period. Fulton Bank N.A. raised its holdings in shares of Danaher by 2.7% in the fourth quarter. Fulton Bank N.A. now owns 10,516 shares of the conglomerate’s stock valued at $2,414,000 after buying an additional 280 shares during the last quarter. Norway Savings Bank boosted its stake in shares of Danaher by 10.7% during the fourth quarter. Norway Savings Bank now owns 6,185 shares of the conglomerate’s stock worth $1,420,000 after buying an additional 596 shares during the period. Finally, Bangor Savings Bank grew its holdings in shares of Danaher by 14.4% during the fourth quarter. Bangor Savings Bank now owns 1,700 shares of the conglomerate’s stock worth $390,000 after buying an additional 214 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several analysts have commented on the company. Royal Bank of Canada reduced their price objective on Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Stifel Nicolaus lifted their price objective on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research report on Wednesday, October 23rd. Scotiabank started coverage on shares of Danaher in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective on the stock. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Finally, Raymond James dropped their price target on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $286.80.

Danaher Price Performance

NYSE DHR traded down $1.20 during trading hours on Wednesday, reaching $237.90. The company’s stock had a trading volume of 2,507,361 shares, compared to its average volume of 2,862,771. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The stock has a market cap of $171.83 billion, a PE ratio of 45.40, a PEG ratio of 4.33 and a beta of 0.83. The company’s 50-day moving average is $236.17 and its two-hundred day moving average is $254.11. Danaher Co. has a fifty-two week low of $222.53 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same period last year, the company posted $2.02 EPS. The company’s revenue was up 3.1% on a year-over-year basis. Analysts forecast that Danaher Co. will post 7.5 EPS for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be paid a $0.27 dividend. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.45%. Danaher’s payout ratio is currently 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.